Skip to content

Medistock

Active
Private limited company (pre-2019)founded 2010active for 16 yearsKBO/BCE: BE 0824.494.456

From the official registers: KBO 13 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

The computed 12-month bankruptcy probability of Medistock is 2.2% (moderate). The 2025 annual accounts show equity of €107,438 and a net result of -€6,234. Equity has been growing by about 8.7% per year since 2018. Its solvency ranks better than 95% of 22,726 sector peers (NACE 47, financial year 2025). The company has been active since 2010 and the Belgian Official Gazette contains no insolvency signals. The KBO does carry 2 administrative register entries.

Overview

Official details

KBO
Status
Active since 30-03-2010 Normal situation
Legal form
Private limited company (pre-2019)
Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses NACE 47741and 1 other
Financial year end
31 December
Peppol
Reachable since 01-04-2026

Board and ownership

Board
  • Boxelaar MartinusDirector

Financial position

55 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
2.2%
Annual accounts 2025
Gross margin
€12,696
Turnover
≈ €140,000
estimated
Loss
€6,234
Equity
€107,438
Total assets
€109,572
2025 accounts filed 13 days after the deadline
Filed on 13-08-2026at the National Bank
Score breakdownraises risk1 change of registered office in 24 monthsNo registered site in the KBO2 ex-officio strike-offs in the KBOlowers riskEquity €107,438 (98.1% of total assets)Show the evidence

Checked score

Score 2025
55 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 70% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2023
Strong
Solvency 100=
equity 98.1% of total assets
Liquidity 67-20
short-term debt 1.9% · cash 13.5%
Profitability 62+5
return on assets -5.7%
Bankruptcy probability within 12 months
2.2% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 0.6% 12-2024: 0.6%● unchanged vs 11-2024 01-2025: 0.6%● unchanged vs 12-2024 02-2025: 0.6%● unchanged vs 01-2025 03-2025: 0.6%● unchanged vs 02-2025 04-2025: 0.6%● unchanged vs 03-2025 05-2025: 0.6%● unchanged vs 04-2025 06-2025: 0.6%● unchanged vs 05-2025 07-2025: 0.6%● unchanged vs 06-2025lowest value 08-2025: 0.8%▲ +0.2 percentage points vs 07-2025 09-2025: 0.8%● unchanged vs 08-2025 10-2025: 1.2%▲ +0.4 percentage points vs 09-2025 11-2025: 1.2%● unchanged vs 10-2025 12-2025: 9.3%▲ +8.1 percentage points vs 11-2025 01-2026: 15.0%▲ +5.7 percentage points vs 12-2025 02-2026: 15.0%● unchanged vs 01-2026 03-2026: 15.2%▲ +0.2 percentage points vs 02-2026 04-2026: 14.2%▼ -1.0 percentage point vs 03-2026 05-2026: 14.2%● unchanged vs 04-2026 06-2026: 14.2%● unchanged vs 05-2026 07-2026: 17.5%▲ +3.3 percentage points vs 06-2026 08-2026: 23.4%▲ +5.9 percentage points vs 07-2026highest value 09-2026: 2.2%▼ -21.2 percentage points vs 08-2026 10-2026: 2.2%● unchanged vs 09-2026
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 33.81 (5.18 in 2023), above the usual 1.5. Short-term debt is 1.9% and cash 13.5% of total assets. 1.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 73% on liquidity and 43% on profitability.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
raises risk · No registered site in the KBO
KBO · seat and establishments
raises risk · 2 ex-officio strike-offs in the KBO
KBO publications
lowers risk · Equity €107,438 (98.1% of total assets)
NBB · annual accounts
raises risk · 2025 accounts filed 13 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-08-2026, 13 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
13 days late
2023
42 days early
2022
42 days late
2021
16 days late
2019
1 day early
2018
20 days late
2017
28 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 11 days after the deadline. In the sector (NACE 47), the median for financial year 2023 was on the deadline day, and 48% of those companies filed late.

raises risk · Administrative warnings in the KBO publications
The FPS Economy published 2 notices about the company, such as a strike-off for address, accounts or UBO, or their withdrawal.
KBO publications
Publications
UBO non-complianceAddress struck
Searched, nothing found (1)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline

Key points

  • Positive: Higher solvency than 95% of companies in retail tradesector median 33.2% · 22,726 companies 98.1% View
  • Caution: 2 loss-making years in a rowloss in financial year 2025 -€6,234 View

Documents

Annual accounts at the NBB

All 13 annual accounts

Articles and registers

Key facts about Medistock

What is the company number of Medistock?
The company number of Medistock is 0824.494.456. The VAT number is the same number with BE in front: BE 0824.494.456.
What does Medistock do?
According to the KBO register, the main activity is retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741).
What is the legal form of Medistock?
The legal form of Medistock is Private limited company (pre-2019) (BVBA).
When was Medistock founded?
Medistock was founded on 30-03-2010.
Is Medistock still active?
Yes, Medistock is an active enterprise in the KBO register.Company details
What is the turnover of Medistock?
The turnover in financial year 2025 is ≈ €140,000. This figure is estimated from the gross margin of €12,696 and 118 comparable companies (NACE 477). It probably lies between €49,000 and €280,000. It is a rough estimate.Financials
Is Medistock profitable?
In financial year 2025, Medistock made a loss of €6,234.
Where can I find the annual accounts of Medistock?
Medistock filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Medistock due?
Medistock must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Comparable companies

These companies have the same main activity as Medistock: retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741). They are comparable in size and age: total assets between €67,600 and €171,000, founded between 2006 and 2015.

CompanyTotal assetsGross margin
Medistock€109,572€12,696
Be.Nursing Sint-Lambrechts-Woluwe€171,296€13,435
MedCaT Temse€88,066€7,715
AZAIRE PHYTO PRODUCT Flobecq€68,750€15,791
CHEMLIRO Roeselare€67,557€16,559
ETABLISSEMENTS GOORMAN Charleroi€75,147€7,733
SENTILEGES Tournai€88,154€11,557
Full comparison

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.